A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
NCT05431777
·
clinicaltrials.gov ↗
COMPLETED
Status
79
Enrollment
INDUSTRY
Sponsor class
Conditions
Urothelial Carcinoma
Interventions
DRUG:
Avelumab
Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany